A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects

Science

Volumn 283, Issue 5405, 1999, Pages 1158-1161

  Yamagishi, Hiroyuki ^a   Garg, Vidu ^a   Matsuoka, Rumiko ^c   Thomas, Tiffani ^a   Srivastava, Deepak ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 22Q; CHROMOSOME DELETION; CRANIOFACIAL MALFORMATION; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC LINKAGE; HEART DISEASE; HUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA, THORACIC; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 22; CRANIOFACIAL ABNORMALITIES; DNA-BINDING PROTEINS; EMBRYO; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HEART DEFECTS, CONGENITAL; HUMANS; MICE; NEURAL CREST; PHENOTYPE; PROTEINS; TRANSCRIPTION FACTORS; UBIQUITINS; ZEBRAFISH PROTEINS;

EID: 0033582626     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.283.5405.1158     Document Type: Article

References (49)

1. J. I. E. Hoffman, Pediatr. Cardiol. 16, 103 (1995).
2. D. C. Fyler, in Nadas' Pediatric Cardiology, Trends, A. S. Nadas and D. C. Fyler, Eds. (Hanley & Belfus, Philadelphia, 1992), pp. 273-280; L. H. S. Van Mierop and L. M. Kutsche, Am. J. Cardiol. 56, 133 (1986).
3. D. C. Fyler, in Nadas' Pediatric Cardiology, Trends, A. S. Nadas and D. C. Fyler, Eds. (Hanley & Belfus, Philadelphia, 1992), pp. 273-280; L. H. S. Van Mierop and L. M. Kutsche, Am. J. Cardiol. 56, 133 (1986).
4. M. L. Kirby, Trends Cardiovasc. Med. 3, 18 (1993).
5. D. A. Driscoll et al., Am. J. Med. Genet. 50, 924 (1992); D. I. Wilson, J. Burn, P. Scambler, J. Goodship, J. Med. Genet. 30, 852 (1993); J. Burn et al., ibid., p. 822.
6. D. A. Driscoll et al., Am. J. Med. Genet. 50, 924 (1992); D. I. Wilson, J. Burn, P. Scambler, J. Goodship, J. Med. Genet. 30, 852 (1993); J. Burn et al., ibid., p. 822.
7. D. A. Driscoll et al., Am. J. Med. Genet. 50, 924 (1992); D. I. Wilson, J. Burn, P. Scambler, J. Goodship, J. Med. Genet. 30, 852 (1993); J. Burn et al., ibid., p. 822.
8. D. A. Driscoll et al., J. Med. Genet. 30, 813 (1993); E. Goldmuntz et al., J. Am. Coll. Cardiol. 32, 492 (1998); M. B. Lewin et al., Am. J. Cardiol. 80, 493 (1997).
9. D. A. Driscoll et al., J. Med. Genet. 30, 813 (1993); E. Goldmuntz et al., J. Am. Coll. Cardiol. 32, 492 (1998); M. B. Lewin et al., Am. J. Cardiol. 80, 493 (1997).
10. D. A. Driscoll et al., J. Med. Genet. 30, 813 (1993); E. Goldmuntz et al., J. Am. Coll. Cardiol. 32, 492 (1998); M. B. Lewin et al., Am. J. Cardiol. 80, 493 (1997).
11. M. L. Kirby and K. L. Waldo, Circulation 82, 332 (1990).
12. W. Gong et al., Hum. Mol. Genet. 5, 789 (1996); B. Dallapiccola, A. Pizzuti, G. Novelli, Am. J. Hum. Genet. 59, 7 (1996); N. Galili et al., Genome Res. 7, 17 (1997); A. Puech et al., Proc. Natl. Acad. Sci. U.S.A. 94, 14608 (1997); B. S. Emanuel, M. L. Budarf, P. J. Scambler, in Heart Development, R. P. Harvey and N. Rosenthal, Eds. (Academic Press, San Diego, 1998), pp. 463-478.
13. W. Gong et al., Hum. Mol. Genet. 5, 789 (1996); B. Dallapiccola, A. Pizzuti, G. Novelli, Am. J. Hum. Genet. 59, 7 (1996); N. Galili et al., Genome Res. 7, 17 (1997); A. Puech et al., Proc. Natl. Acad. Sci. U.S.A. 94, 14608 (1997); B. S. Emanuel, M. L. Budarf, P. J. Scambler, in Heart Development, R. P. Harvey and N. Rosenthal, Eds. (Academic Press, San Diego, 1998), pp. 463-478.
14. W. Gong et al., Hum. Mol. Genet. 5, 789 (1996); B. Dallapiccola, A. Pizzuti, G. Novelli, Am. J. Hum. Genet. 59, 7 (1996); N. Galili et al., Genome Res. 7, 17 (1997); A. Puech et al., Proc. Natl. Acad. Sci. U.S.A. 94, 14608 (1997); B. S. Emanuel, M. L. Budarf, P. J. Scambler, in Heart Development, R. P. Harvey and N. Rosenthal, Eds. (Academic Press, San Diego, 1998), pp. 463-478.
15. W. Gong et al., Hum. Mol. Genet. 5, 789 (1996); B. Dallapiccola, A. Pizzuti, G. Novelli, Am. J. Hum. Genet. 59, 7 (1996); N. Galili et al., Genome Res. 7, 17 (1997); A. Puech et al., Proc. Natl. Acad. Sci. U.S.A. 94, 14608 (1997); B. S. Emanuel, M. L. Budarf, P. J. Scambler, in Heart Development, R. P. Harvey and N. Rosenthal, Eds. (Academic Press, San Diego, 1998), pp. 463-478.
16. W. Gong et al., Hum. Mol. Genet. 5, 789 (1996); B. Dallapiccola, A. Pizzuti, G. Novelli, Am. J. Hum. Genet. 59, 7 (1996); N. Galili et al., Genome Res. 7, 17 (1997); A. Puech et al., Proc. Natl. Acad. Sci. U.S.A. 94, 14608 (1997); B. S. Emanuel, M. L. Budarf, P. J. Scambler, in Heart Development, R. P. Harvey and N. Rosenthal, Eds. (Academic Press, San Diego, 1998), pp. 463-478.
17. M. Li et al., Am. J. Med. Genet. 55, A10 (1994); M. L. Budarf et al., Nature Genet. 10, 269 (1995).
18. M. Li et al., Am. J. Med. Genet. 55, A10 (1994); M. L. Budarf et al., Nature Genet. 10, 269 (1995).
19. D. Srivastava, P. Cserjesi, E. N. Olson, Science 270, 1995 (1995).
20. T. Thomas, H. Yamagishi, P. A. Overbeek, E. N. Olson, D. Srivastava, Dev. Biol. 196, 228 (1998).
21. D. Srivastava et al., Nature Genet. 16, 154 (1997); T. Thomas et al., Development 125, 3005 (1998); D. Srivastava, unpublished observations.
22. D. Srivastava et al., Nature Genet. 16, 154 (1997); T. Thomas et al., Development 125, 3005 (1998); D. Srivastava, unpublished observations.
23. D. Srivastava et al., Nature Genet. 16, 154 (1997); T. Thomas et al., Development 125, 3005 (1998); D. Srivastava, unpublished observations.
24. Y. Kurihara et al., Nature 368, 703 (1994); Y. Kurihara et al., J. Clin. Invest. 96, 293 (1995); D. Clouthier et al., Development 125, 813 (1998).
25. Y. Kurihara et al., Nature 368, 703 (1994); Y. Kurihara et al., J. Clin. Invest. 96, 293 (1995); D. Clouthier et al., Development 125, 813 (1998).
26. Y. Kurihara et al., Nature 368, 703 (1994); Y. Kurihara et al., J. Clin. Invest. 96, 293 (1995); D. Clouthier et al., Development 125, 813 (1998).
27. Total RNA (1 μg) from wild-type and dHAND-null E9.5 hearts was treated with deoxyribonuclease and used to generate cDNA by the SMART cDNA synthesis kit (Clontech). PCR-Select (Clontech) was used for subtractive hybridization. Briefly, two pools of Rsa I-digested wild-type cDNA were used as tester and ligated to unique adapters. Rsa I-digested dHAND-null cDNA was used as driver without adapters. Hybridization of the tester population with excess driver and amplification of subtracted species with the two unique adapters in the tester cDNA produced a pool of PCR-amplified fragments theoretically present in wild-type, but not dHAND mutant, RNA. The PCR products were cloned and sequenced.
28. E. S. Johnson et al., J. Biol. Chem. 270, 17442 (1995).
29. A. Pizzuti et al., Hum. Mol. Genet. 6, 259 (1997); G. Novelli et al., Biochim. Biophys. Acta 1396, 158 (1998); A. Botta et al., Cytogenet. Cell Genet. 77, 264 (1997).
30. A. Pizzuti et al., Hum. Mol. Genet. 6, 259 (1997); G. Novelli et al., Biochim. Biophys. Acta 1396, 158 (1998); A. Botta et al., Cytogenet. Cell Genet. 77, 264 (1997).
31. A. Pizzuti et al., Hum. Mol. Genet. 6, 259 (1997); G. Novelli et al., Biochim. Biophys. Acta 1396, 158 (1998); A. Botta et al., Cytogenet. Cell Genet. 77, 264 (1997).
32. Total RNA was purified from hearts of wild-type and dHAND-null embryos at E9.5 and used for cDNA synthesis: PCR analysis was performed with oligonucleotides specific for mouse Ufd1 (upper, 5′-GGAGAAAGGAGGGAAGATAA-3′; lower, 5′-CGAAGTAGGAGAAGTTGGAA-3′) or mouse Cdc45 (upper, 5′-ACCACTTCATCCAGGCTCTC-3′; lower, 5′-GGT- GCTTTCTGCTGCCTTCT-3′) under the following conditions: 94°C for 5 min; 94°C for 1 min, 52°C for 1 min, and 72°C for 1 min; and 72°C for 7 min. PCR products were analyzed by agarose gel electrophoresis after serial cycles in the linear range of amplification. RNA loading was controlled for by amplification of the housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (G3PDH). Negative controls were performed for each sample using non-reverse-transcribed RNA. A Southern blot of the samples was hybridized for UFD1L or G3PDH.
33. Human metaphase chromosome slides were prepared from Epstein-Barr virus-transformed lymphoblastoid cell lines or peripheral blood. Slides were hybridized with a genomic clone encompassing UFD1L that had been obtained by screening a human P1 artificial chromosome library with UFD1L-specific primers. FISH analysis was performed according to R. Matsuoka et al. [Hum. Genet. 103, 70 (1998)]. Patients with 22q11 deletion had been characterized by FISH using the N25 (Oncor) marker that does not encompass UFD1L.
34. Whole-mount in situ hybridizations were performed with digoxygenin-labeled antisense riboprobes synthesized from the 700-bp open reading frame and the 250-bp 3′ untranslated region of mouse UFD1L cDNA (9). Embryos were photographed with and without clearing in benzyl benzoate:methyl salicylate (1:1). For histologic analysis, stained embryos were embedded in paraffin after fixation. Transverse and sagittal sections were made at 8-μm intervals throughout the embryos.
35. M. L. Kirby, T. F. Gale, D. E. Stewart, Science 220, 1059 (1983).
36. E. N. Olson and D. Srivastava, ibid. 272, 1069 (1996); M. L. Kirby and K. L. Waldo, Circ. Res. 77, 211 (1995).
37. E. N. Olson and D. Srivastava, ibid. 272, 1069 (1996); M. L. Kirby and K. L. Waldo, Circ. Res. 77, 211 (1995).
38. 32P-labeled UFD1L or CDC45 cDNA.
39. Thymic tissue was collected from patients who were undergoing surgical repair of CHD, and total RNA was extracted and used for cDNA synthesis. Northern analysis was performed on 20 μg of total thymic RNA and hybridized to a UFD1L cDNA probe. HIRA-and CDC45-specific amplimers were used to amplify the respective cDNAs. HIRA amplimers were: upper, 5′-GACGGCTCTGTGGCATTCCT-3′; lower, 5′-GCCATCTGCTGTCCGAGTCT-3′. CDC45 amplimers were: upper, 5′-GCCTTGTTCCAGTGTGACCA-3′; lower, 5′-GTTCTCCTCATCCTCGTTCC-3′.
40. S. C. Daw et al., Nature Genet. 13, 458 (1996).
41. L. G. Wilming et al., Hum. Mol. Genet. 6, 247 (1997); P. Magnaghi et al., Nature Genet. 20, 74 (1998).
42. L. G. Wilming et al., Hum. Mol. Genet. 6, 247 (1997); P. Magnaghi et al., Nature Genet. 20, 74 (1998).
43. H. Yamagishi, V. Garg, D. Srivastava, unpublished observations.
44. J. McKie et al., Genome Res. 8, 834 (1998).
45. T. H. Shaikh et al., Am. J. Hum. Genet. 63, A193 (1998).
46. M. Scheffner, J. M. Huibregtse, R. D. Vierstra, P. M. Howley, Cell 75, 495 (1993); C. Sears, J. Olesen, D. Rubin, D. Finley, T. Maniatis, J. Biol. Chem. 273, 1409 (1998).
47. M. Scheffner, J. M. Huibregtse, R. D. Vierstra, P. M. Howley, Cell 75, 495 (1993); C. Sears, J. Olesen, D. Rubin, D. Finley, T. Maniatis, J. Biol. Chem. 273, 1409 (1998).
48. L. Monney et al., J. Biol. Chem. 273, 6121 (1998).
49. We thank R. Schultz and A. Bowcock for helpful discussions and assistance with genetic analyses, members of the pediatric cardiology and cardiothoracic surgery divisions for assistance with tissue collection, other members of the Srivastava laboratory for critical discussion, J. L. Goldstein, M. S. Brown, E. N. Olson, and H. H. Hobbs for critical review of this manuscript, and J. Page for manuscript preparation. Supported by grants to D.S. from NIH (R01HL57181-01) and March of Dimes.